Orbital Therapeutics News

This is selected news for Orbital Therapeutics, which is filed under Sectors / Healthtech. There are 7 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
11/16/2022 Vineeta Agarwala on the promise—and limits—of AI in drug discovery
... Fast facts Did graduate work in computational biology and human genetics Serves on a number of company boards, including BigHat Biosciences, GC Therapeutics, Memora Health, Orbital Therapeutics, Pearl Health, Thyme Care, and Waymark Is board certified in internal medicine and continues to see patients at Stanford as an adjunct clinical ...
McKinsey
9/7/2022 Orbital Therapeutics Launches to Advance New Frontiers of Science with the Next Generation of Innovative RNA Medicines
... Biopharma Executives Initial Funding Led by ARCH Venture Partners with Participation from a16z Bio + Health and Newpath Partners CAMBRIDGE, Mass., September 07, 2022 --( BUSINESS WIRE )--Orbital Therapeutics launched today with a vision of enhancing global health by unleashing the full potential of RNA medicines to treat human disease in ways ...
Yahoo News
9/7/2022 Orbital Therapeutics Launches to Advance New Frontiers of Science with the Next Generation of Innovative RNA Medicines | Business Wire
CAMBRIDGE, Mass.--( BUSINESS WIRE )--Orbital Therapeutics launched today with a vision of enhancing global health by unleashing the full potential of RNA medicines to treat human disease in ways that were not previously possible. ‚AuThe breakthroughs in RNA therapeutics over the last decade have been remarkable achievements by the biopharmaceutical ...
Business Wire
9/7/2022 RNA and Gene Editing Pioneers Launch Orbital Therapeutics
Orbital Therapeutics, a Cambridge, Massachusetts-based RNA medicines startup, has launched with a view to developing new RNA therapeutics not including those based on RNA interference (i). The initial funding for Orbital is led by Arch Venture Partners and a16z Bio + Health and Newpath Partners have also contributed funds. The ...
Inside Precision Medicine
9/7/2022 Beam-linked startup launches with an eye on the next generation of RNA drugs
Dive Brief: Orbital Therapeutics, a Cambridge, Mass.-based biotechnology startup focused on RNA-based medicines, launched Wednesday with a research collaboration with gene editing company Beam Therapeutics. The new company will initially be run on an interim basis by Beam's chief scientific officer Giuseppe Ciaramella and has access to ...
BioPharma Dive
9/7/2022 Orbital Therapeutics Launches to Advance New Frontiers of Science with the Next Generation of Innovative RNA Medicines
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep 7, 2022-- Orbital Therapeutics launched today with a vision of enhancing global health by unleashing the full potential of RNA medicines to treat human disease in ways that were not previously possible. ‚AuThe breakthroughs in RNA therapeutics over the last decade have been remarkable achievements ...
Business Wire